Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDK9 anticorps (AA 231-372)

CDK9 Reactivité: Humain WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2172831
  • Antigène Voir toutes CDK9 Anticorps
    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
    Épitope
    • 25
    • 14
    • 10
    • 10
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 231-372
    Reactivité
    • 96
    • 46
    • 20
    • 7
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 92
    • 4
    • 2
    Lapin
    Clonalité
    • 86
    • 12
    Polyclonal
    Conjugué
    • 39
    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp CDK9 est non-conjugé
    Application
    • 74
    • 31
    • 25
    • 25
    • 15
    • 13
    • 10
    • 8
    • 8
    • 6
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
     Réactivité croisée
    Humain
    Homologie
    Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human CDK9
    Isotype
    IgG
    Top Product
    Discover our top product CDK9 Anticorps primaire
  • Indications d'application
    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Date de péremption
    12 months
  • Antigène
    CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
    Autre désignation
    CDK9 (CDK9 Produits)
    Synonymes
    anticorps C-2k, anticorps CDC2L4, anticorps CTK1, anticorps PITALRE, anticorps TAK, anticorps wu:fb22e09, anticorps wu:fc06c02, anticorps c-2k, anticorps cdc2l4, anticorps cdk9, anticorps ctk1, anticorps pitalre, anticorps tak, anticorps CDK9, anticorps CG5179, anticorps Dmel\\CG5179, anticorps P-TEF, anticorps P-TEFb, anticorps PTefb, anticorps cyclin dependent kinase 9, anticorps cyclin-dependent kinase 9 (CDC2-related kinase), anticorps cyclin-dependent kinase 9 L homeolog, anticorps cyclin-dependent kinase 9, anticorps Cyclin-dependent kinase 9, anticorps cyclin-dependent kinase 9 S homeolog, anticorps CDK9, anticorps cdk9, anticorps cdk9.L, anticorps Cdk9, anticorps cdk9.S
    Sujet

    Synonyms: TAK, C-2k, CTK1, CDC2L4, PITALRE, Cyclin-dependent kinase 9, Cell division cycle 2-like protein kinase 4, Cell division protein kinase 9, Serine/threonine-protein kinase PITALRE, Tat-associated kinase complex catalytic subunit, CDK9

    Background: Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3, integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein, the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth.

    ID gène
    1025
    UniProt
    P50750
    Pathways
    Cycle Cellulaire
Vous êtes ici:
Support technique